{"id":"W4414377875","doi":"10.1016/j.jtcvs.2025.09.017","title":"TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non–small cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; AstraZeneca","keywords":"Clinical endpoint; Stage (stratigraphy); Adenocarcinoma; Adjuvant; Lung cancer; Randomized controlled trial; Phases of clinical research; Adjuvant therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002676244,0.0002613197,0.001934726,0.0007377628,0.0001086561,0.00002533435,0.0001071049,0.0001104433,0.00001535483],"category_scores_gemma":[0.0003845059,0.0001845875,0.0005009833,0.0005225554,0.0001642983,0.0001294848,0.000184876,0.0006008951,1.863118e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001915965,"about_ca_system_score_gemma":0.0007465279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001209693,"about_ca_topic_score_gemma":0.0002791685,"domain_scores_codex":[0.9971473,0.0007134061,0.0008161889,0.0003759334,0.0005796452,0.000367498],"domain_scores_gemma":[0.998099,0.0005445741,0.0003636473,0.0004035184,0.0004100419,0.00017923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008252896,0.001541869,0.7282194,0.002328407,0.009335208,0.008682042,0.00394685,0.0001951313,0.0007298218,0.000001898715,0.0007370816,0.2360293],"study_design_scores_gemma":[0.02127395,0.002940714,0.9345674,0.00364324,0.01095996,0.0007114221,0.01585922,0.0003645321,0.007782744,0.00002935063,0.00130879,0.000558664],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9077185,0.0902601,0.0007633483,0.0001442804,0.0002876529,0.0007254189,0.00004964515,0.000006850972,0.00004423287],"genre_scores_gemma":[0.9662141,0.03319066,0.0001518798,0.00005917392,0.0001327569,0.0000464695,0.000002592542,0.00002326075,0.0001791168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2354707,"threshold_uncertainty_score":0.752726,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01563828591311364,"score_gpt":0.3483685570031425,"score_spread":0.3327302710900288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}